．

Material Information - Announcement on Behalf of PharmaEssentia Japan KK: Filing for an Additional Indication of BESREMi (Ropeginterferon alfa-2b) for ET in Japan

Sep 18, 2025

20250918 本公司代日本子公司公告於日本申請新藥BESREMi新增適應症，新增適應症為ET (EN).pdf

Download